{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T13:19:06Z","timestamp":1718889546287},"reference-count":43,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00005-022-00652-x","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T11:07:06Z","timestamp":1649675226000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hydroxychloroquine Therapy and Serum Immunoglobulin Levels in Women with IgG Subclass Deficiency and Systemic Lupus Erythematosus, Sj\u00f6gren Syndrome, and Rheumatoid Arthritis: A Retrospective Study"],"prefix":"10.2478","volume":"70","author":[{"given":"James C.","family":"Barton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Clayborn","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi F.","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"652_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/opo.12131","volume":"34","author":"RA Armstrong","year":"2014","unstructured":"Armstrong RA (2014) When to use the Bonferroni correction. Ophthalmic Physiol Opt 34:502\u2013508","journal-title":"Ophthalmic Physiol Opt"},{"key":"652_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/ard.62.1.83","volume":"62","author":"LJ Badcock","year":"2003","unstructured":"Badcock LJ, Clarke S, Jones PW et al (2003) Abnormal IgA levels in patients with rheumatoid arthritis. Ann Rheum Dis 62:83\u201384","journal-title":"Ann Rheum Dis"},{"key":"652_CR3","first-page":"127","volume":"63","author":"DJ Barrett","year":"1986","unstructured":"Barrett DJ, Ayoub EM (1986) IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol 63:127\u2013134","journal-title":"Clin Exp Immunol"},{"key":"652_CR4","doi-asserted-by":"publisher","first-page":"542706","DOI":"10.1155\/2014\/542706","volume":"2014","author":"JC Barton","year":"2014","unstructured":"Barton JC, Bertoli LF, Barton JC (2014) Comparisons of CVID and IgGSD: referring physicians, autoimmune conditions, pneumovax reactivity, immunoglobulin levels, blood lymphocyte subsets, and HLA-A and -B typing in 432 adult index patients. J Immunol Res 2014:542706","journal-title":"J Immunol Res"},{"key":"652_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cellimm.2015.09.004","volume":"299","author":"JC Barton","year":"2016","unstructured":"Barton JC, Bertoli LF, Barton JC et al (2016) Selective subnormal IgG3 in 121 adult index patients with frequent or severe bacterial respiratory tract infections. Cell Immunol 299:50\u201357","journal-title":"Cell Immunol"},{"key":"652_CR6","doi-asserted-by":"publisher","first-page":"e0216940","DOI":"10.1371\/journal.pone.0216940","volume":"14","author":"J Barton","year":"2019","unstructured":"Barton J, Barton C, Bertoli L (2019) Duration of frequent or severe respiratory tract infection in adults before diagnosis of IgG subclass deficiency. PLoS ONE 14:e0216940","journal-title":"PLoS ONE"},{"key":"652_CR7","unstructured":"Barton JC, Barton JC, Bertoli LF (2022) Hydroxychloroquine therapy and other observations in 132 women with three common IgGSD subtypes. Open Science Framework https:\/\/osf.io\/hbfdc\/. Accessed 02 may 2022"},{"key":"652_CR8","doi-asserted-by":"publisher","first-page":"e0240522","DOI":"10.1371\/journal.pone.0240522","volume":"15","author":"JC Barton","year":"2020","unstructured":"Barton JC, Barton JC, Bertoli LF et al (2020a) Characterization of adult patients with IgG subclass deficiency and subnormal IgG2. PLoS ONE 15:e0240522","journal-title":"PLoS ONE"},{"key":"652_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00005-020-00572-8","volume":"68","author":"JC Barton","year":"2020","unstructured":"Barton JC, Barton JC, Bertoli LF et al (2020b) HLA-A and -B type and haplotype frequencies in IgG subclass deficiency subgroups. Arch Immunol Ther Exp 68:14","journal-title":"Arch Immunol Ther Exp"},{"key":"652_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12865-021-00447-3","volume":"22","author":"JC Barton","year":"2021","unstructured":"Barton JC, Barton JC, Bertoli LF et al (2021) Factors associated with IgG levels in adults with IgG subclass deficiency. BMC Immunol 22:53","journal-title":"BMC Immunol"},{"key":"652_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/096120339200100609","volume":"1","author":"F Blanco","year":"1992","unstructured":"Blanco F, Kalsi J, Ravirajan CT et al (1992) IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases. Lupus 1:391\u2013399","journal-title":"Lupus"},{"key":"652_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/rheumatology\/kez242","volume":"59","author":"ILA Bodewes","year":"2020","unstructured":"Bodewes ILA, Gottenberg JE, van Helden-Meeuwsen CG et al (2020) Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sj\u00f6gren\u2019s syndrome in the JOQUER randomized trial. Rheumatology 59:107\u2013111","journal-title":"Rheumatology"},{"key":"652_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","volume":"38","author":"A Bousfiha","year":"2018","unstructured":"Bousfiha A, Jeddane L, Picard C et al (2018) The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol 38:129\u2013143","journal-title":"J Clin Immunol"},{"key":"652_CR14","unstructured":"Concordia Pharmaceuticals Inc. (2017) Plaquenil\u00ae: Hydroxychloroquine sulfate tablets, USP (package insert information). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/009768s037s045s047lbl.pdf. Accessed 01 jul 2022"},{"key":"652_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2500\/aap.2009.30.3292","volume":"30","author":"HC Crisp","year":"2019","unstructured":"Crisp HC, Quinn JM (2019) Quantitative immunoglobulins in adulthood. Allergy Asthma Proc 30:649\u2013654","journal-title":"Allergy Asthma Proc"},{"key":"652_CR16","doi-asserted-by":"publisher","first-page":"e000152","DOI":"10.1136\/bmjresp-2016-000152","volume":"3","author":"MC de la Torre","year":"2016","unstructured":"de la Torre MC, Toran P, Serra-Prat M et al (2016) Serum levels of immunoglobulins and severity of community-acquired pneumonia. BMJ Open Respir Res 3:e000152","journal-title":"BMJ Open Respir Res"},{"key":"652_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1365-2249.2004.02562.x","volume":"137","author":"P Eriksson","year":"2004","unstructured":"Eriksson P, Andersson C, Ekerfelt C et al (2004) Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjogren\u2019s syndrome, rheumatoid arthritis and healthy controls. Clin Exp Immunol 137:617\u2013620","journal-title":"Clin Exp Immunol"},{"key":"652_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/rheumatology\/keq047","volume":"49","author":"AL Fauchais","year":"2010","unstructured":"Fauchais AL, Ouattara B, Gondran G et al (2010) Articular manifestations in primary Sj\u00f6gren\u2019s syndrome: clinical significance and prognosis of 188 patients. Rheumatology 49:1164\u20131172","journal-title":"Rheumatology"},{"key":"652_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0002-9343(88)90365-8","volume":"85","author":"RI Fox","year":"1988","unstructured":"Fox RI, Chan E, Benton L et al (1988) Treatment of primary Sj\u00f6gren\u2019s syndrome with hydroxychloroquine. Am J Med 85:62\u201367","journal-title":"Am J Med"},{"key":"652_CR20","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/art.30325","volume":"63","author":"C Gabay","year":"2011","unstructured":"Gabay C, Bel M, Combescure C et al (2011) Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis Rheum 63:1486\u20131496","journal-title":"Arthritis Rheum"},{"key":"652_CR21","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1016\/j.jaci.2005.12.680","volume":"117","author":"JG Gibbs","year":"2006","unstructured":"Gibbs JG, Pratt EL, Fisher LH et al (2006) Recurrent pneumonia associated with hydroxychloroquine. J Allergy Clin Immunol 117:S170\u2013S171","journal-title":"J Allergy Clin Immunol"},{"key":"652_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","volume":"151","author":"A Gonzalez-Quintela","year":"2008","unstructured":"Gonzalez-Quintela A, Alende R, Gude F et al (2008) Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol 151:42\u201350","journal-title":"Clin Exp Immunol"},{"key":"652_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.clim.2017.09.013","volume":"183","author":"C Gr\u00f6nwall","year":"2017","unstructured":"Gr\u00f6nwall C, Hardt U, Gustafsson JT et al (2017) Depressed serum IgM levels in SLE are restricted to defined subgroups. Clin Immunol 183:304\u2013315","journal-title":"Clin Immunol"},{"key":"652_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01131.x","volume":"120","author":"L Hammarstr\u00f6m","year":"2000","unstructured":"Hammarstr\u00f6m L, Vorechovsky I, Webster D (2000) Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120:225\u2013231","journal-title":"Clin Exp Immunol"},{"key":"652_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00005-019-00556-3","volume":"67","author":"A Khokar","year":"2019","unstructured":"Khokar A, Gupta S (2019) Clinical and immunological features of 78 adult patients with primary selective IgG subclass deficiencies. Arch Immunol Ther Exp 67:325\u2013334","journal-title":"Arch Immunol Ther Exp"},{"key":"652_CR26","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3346\/jkms.2016.31.10.1560","volume":"31","author":"JH Kim","year":"2016","unstructured":"Kim JH, Park S, Hwang YI et al (2016) Immunoglobulin G subclass deficiencies in adult patients with chronic airway diseases. J Korean Med Sci 31:1560\u20131565","journal-title":"J Korean Med Sci"},{"key":"652_CR27","first-page":"560","volume":"12","author":"AK Knight","year":"2005","unstructured":"Knight AK, Cunningham-Rundles C (2005) Oxcarbazepine-induced immunoglobulin deficiency. Clin Diagn Lab Immunol 12:560\u2013561","journal-title":"Clin Diagn Lab Immunol"},{"key":"652_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/clin.1997.4386","volume":"84","author":"C Lacombe","year":"1997","unstructured":"Lacombe C, Aucouturier P, Preud\u2019homme JL (1997) Selective IgG1 deficiency. Clin Immunol Immunopathol 84:194\u2013201","journal-title":"Clin Immunol Immunopathol"},{"key":"652_CR29","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s10067-009-1224-x","volume":"28","author":"GG Lin","year":"2009","unstructured":"Lin GG, Li JM (2009) IgG subclass serum levels in systemic lupus erythematosus patients. Clin Rheumatol 28:1315\u20131318","journal-title":"Clin Rheumatol"},{"key":"652_CR30","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00296-009-1330-8","volume":"30","author":"G Lin","year":"2010","unstructured":"Lin G, Li J (2010) Elevation of serum IgG subclass concentration in patients with rheumatoid arthritis. Rheumatol Int 30:837\u2013840","journal-title":"Rheumatol Int"},{"key":"652_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1590\/S0482-50042010000300007","volume":"50","author":"AP Mantovani","year":"2010","unstructured":"Mantovani AP, Monclaro MP, Skare TL (2010) Prevalence of IgA deficiency in adult systemic lupus erythematosus and the study of the association with its clinical and autoantibody profiles. Rev Bras Reumatol 50:273\u2013282","journal-title":"Rev Bras Reumatol"},{"key":"652_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12865-019-0310-3","volume":"20","author":"AR Parker","year":"2019","unstructured":"Parker AR, Skold M, Harding S et al (2019) Pneumococcal vaccination responses in adults with subnormal IgG subclass concentrations. BMC Immunol 20:29","journal-title":"BMC Immunol"},{"key":"652_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/ard.48.7.542","volume":"48","author":"K Pavelka Jr","year":"1989","unstructured":"Pavelka K Jr, Sen KP, Peliskova Z et al (1989) Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens. Ann Rheum Dis 48:542\u2013546","journal-title":"Ann Rheum Dis"},{"key":"652_CR34","doi-asserted-by":"publisher","first-page":"e15013","DOI":"10.1111\/dth.15013","volume":"34","author":"K Pelka","year":"2021","unstructured":"Pelka K, Matyja-Bednarczyk A, Wojas-Pelc A et al (2021) Hydroxychloroquine does not impair antibody response to 13-valent pneumococcal conjugate vaccine in patients with cutaneous lupus erythematosus-A pilot study. Dermatol Ther 34:e15013","journal-title":"Dermatol Ther"},{"key":"652_CR35","first-page":"202","volume":"10","author":"U Schauer","year":"2003","unstructured":"Schauer U, Stemberg F, Rieger CH et al (2003) Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults. Clin Diagn Lab Immunol 10:202\u2013207","journal-title":"Clin Diagn Lab Immunol"},{"key":"652_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1056\/NEJM198007243030402","volume":"303","author":"GR Siber","year":"1980","unstructured":"Siber GR, Schur PH, Aisenberg AC et al (1980) Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 303:178\u2013182","journal-title":"N Engl J Med"},{"key":"652_CR37","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1159\/000234258","volume":"82","author":"T S\u00f6derstr\u00f6m","year":"1987","unstructured":"S\u00f6derstr\u00f6m T, S\u00f6derstr\u00f6m R, Avanzini A et al (1987) Immunoglobulin G subclass deficiencies. Int Arch Allergy Immunol 82:476\u2013480","journal-title":"Int Arch Allergy Immunol"},{"key":"652_CR38","doi-asserted-by":"publisher","first-page":"100025","DOI":"10.1016\/j.jtauto.2019.100025","volume":"2","author":"S Swain","year":"2019","unstructured":"Swain S, Selmi C, Gershwin ME et al (2019) The clinical implications of selective IgA deficiency. J Transl Autoimmun 2:100025","journal-title":"J Transl Autoimmun"},{"key":"652_CR39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/1744666X.2019.1624527","volume":"15","author":"EH van der Heijden","year":"2019","unstructured":"van der Heijden EH, Hartgring SA, Kruize AA et al (2019) Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sj\u00f6gren\u2019s syndrome. Expert Rev Clin Immunol 15:801\u2013808","journal-title":"Expert Rev Clin Immunol"},{"key":"652_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1046\/j.1365-2249.1999.01023.x","volume":"118","author":"DA Van Kessel","year":"1999","unstructured":"Van Kessel DA, Horikx PE, Van Houte AJ et al (1999) Clinical and immunological evaluation of patients with mild IgG1 deficiency. Clin Exp Immunol 118:102\u2013107","journal-title":"Clin Exp Immunol"},{"key":"652_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03009747609099920","volume":"5","author":"EM Veys","year":"1976","unstructured":"Veys EM, Gabriel PA, Coigne E et al (1976) Rheumatoid factor and serum IgG, IgM and IgA levels in rheumatoid arthritis with vasculitis. Scand J Rheumatol 5:1\u20136","journal-title":"Scand J Rheumatol"},{"key":"652_CR42","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191\u20132194","journal-title":"JAMA"},{"key":"652_CR43","doi-asserted-by":"publisher","first-page":"e387","DOI":"10.1097\/MD.0000000000000387","volume":"94","author":"H Zhang","year":"2015","unstructured":"Zhang H, Li P, Wu D et al (2015) Serum IgG subclasses in autoimmune diseases. Medicine 94:e387","journal-title":"Medicine"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-022-00652-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00005-022-00652-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-022-00652-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:49Z","timestamp":1704228589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00005-022-00652-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1007\/s00005-022-00652-x","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"5 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}],"article-number":"14"}}